文献速递消化内镜

静脉输注5%葡萄糖减少深度镇静胃肠镜后头晕的随机对照试验

Intravenous dextrose during emergence from deep sedation reduces postprocedural dizziness in adults undergoing gastrointestinal endoscopy: a randomized controlled trial.
PubMed 文献 · Gastrointest Endosc · 2025-08-18

该单中心前瞻性双盲随机对照试验纳入102例深度镇静胃肠镜成人,比较苏醒期静脉输注200 mL 5%葡萄糖与0.9%氯化钠(400 mL/h)的效果。

要点

  • 深度镇静胃肠镜苏醒期静脉输注5%葡萄糖可降低术后头晕发生率和严重程度。
  • 5%葡萄糖组恢复质量评分更优,苏醒时间和术后恶心呕吐严重程度无显著差异。
  • 需治疗人数为3.4,提示临床获益具有实际意义。

核心结论

  • 深度镇静胃肠镜苏醒期静脉输注5%葡萄糖可显著降低术后头晕发生率和严重程度,并呈时间依赖性保护效应,需治疗人数为3.4。

研究设计与样本

  • 单中心、前瞻性、双盲、随机对照试验,纳入102例深度镇静下接受胃肠镜的成人。
  • 干预组苏醒期静脉输注200 mL 5%葡萄糖,对照组输注0.9%氯化钠,速率均为400 mL/h。

临床怎么用

  • 对于深度镇静下接受胃肠镜的成人,可考虑在苏醒期静脉输注5%葡萄糖以减少术后头晕。
  • 该干预未显著延长苏醒时间或加重术后恶心呕吐,但需注意未来研究应纳入糖尿病患者并比较林格液。

局限性

  • 单中心研究,样本量102例,结论需大规模多中心研究验证。
  • 研究未纳入糖尿病患者,且未与林格液比较。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Dizziness is a central symptom of postoperative fatigue syndrome after gastrointestinal endoscopy under deep sedation, affecting the quality of postoperative recovery, elevating health care costs, and increasing the risk of falls. Preliminary studies suggest that dextrose supplementation may provide symptomatic relief, but evidence for optimal dosage and safety remains limited. This randomized controlled trial aimed to assess whether intravenous 5% dextrose during emergence from deep sedation could reduce postprocedural dizziness in adults undergoing gastrointestinal endoscopy under deep sedation. METHODS: This single-center, prospective, double-blind, randomized controlled trial enrolled 102 adults undergoing gastrointestinal endoscopy under deep sedation. Participants were randomized to receive 200 mL of intravenous 5% dextrose (intervention) or 0.9% sodium chloride (control) at a rate of 400 mL/h during emergence from deep sedation. The primary outcomes were the incidence and severity of dizziness. Secondary outcomes included quality of recovery, emergence time, and severity of postoperative nausea and vomiting (PONV). RESULTS: There was a significant difference in the overall incidence of dizziness within 30 minutes postoperatively (P = .002). Dizziness severity was significantly reduced in the dextrose group at both 15 minutes (P = .005) and 30 minutes postoperatively (P < .001). The interaction between intervention and time was also significant (odds ratio = 0.058, P < .001). The dextrose group exhibited a better Quality of Recovery-40 score (P = .030). However, the 5% dextrose group showed no statistically significant differences in emergence time (P = .349) or PONV severity (30 minutes, P = .091; 2 hours, P = .080) compared with the control group. CONCLUSIONS: This study demonstrates that intravenous 5% dextrose administered during emergence from deep sedation significantly reduces the incidence and severity of postprocedural dizziness in adults undergoing gastrointestinal endoscopy, with a potent time-dependent protective effect and a clinically impactful number needed to treat of 3.4. Future large-scale, multicenter studies with rigorous designs are needed to validate these findings. Such studies should include diabetic patients and compare dextrose against Ringer's solution.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Wang L, Cheng L, Jiang Y, et al. Intravenous dextrose during emergence from deep sedation reduces postprocedural dizziness in adults undergoing gastrointestinal endoscopy: a randomized controlled trial. Gastrointest Endosc. 2025. PMID: 40835036. doi:10.1016/j.gie.2025.08.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。